According to a report in Financial Times Deutschland the pharmaceutical arm of Altana is a potential target for a range of high profile buyers. These could include EQT in collaboration with Hexal founders Thomas and Andreas Strüngmann and ex-Merck head Bernhard Scheuble; KKR; Belgian chemical and pharmaceutical company Solvay and Danish Nyomed, which is backed by Nordic Capital, Blackstone and Credit Suisse Private Equity.
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater